Product Information
BUPRENORPHINE 5 MCG/HR PATCH is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $23.8187 per EA under NDC 50742037204. Its NADAC has been published 144 times since Nov 22, 2023.
FDA first approved this application on Sep 23, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 ug/h
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742037204
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA210272FDA Approved
9/23/2021
TE Code
AB
On Market Since
11/1/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 5 MCG/HR PATCH has been published 144 times since Nov 22, 2023, and over the history we have for it it has declined 37.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.8187 per EA |
|---|---|
| All-time high | $37.9656 (Dec 13, 2023) |
| All-time low | $19.0169 (May 22, 2024) |
| 52-week high | $23.9718 |
| 52-week low | $20.8287 |
| Median price | $21.8747 |
| Average price | $22.9759 |
| Largest weekly change | +31.2% (Jun 19, 2024) |
| Weeks tracked | 144 |
| Tracking since | Nov 22, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 5 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 5 MCG/HR PATCH, manufactured by Ingenus Pharmaceuticals LLC, is $23.8187 per EA (NDC 50742037204), effective Aug 19, 2026.
How has the price of BUPRENORPHINE 5 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 5 MCG/HR PATCH has declined 37.3%. It has been tracked across 144 weekly CMS publications since Nov 22, 2023.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 5 MCG/HR PATCH?
Since Nov 22, 2023, the NADAC for BUPRENORPHINE 5 MCG/HR PATCH has ranged from a low of $19.0169 (May 22, 2024) to a high of $37.9656 (Dec 13, 2023), with a median of $21.8747 per EA.
Are there cheaper alternatives to BUPRENORPHINE 5 MCG/HR PATCH?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 5 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE 5 MCG/HR PATCH?
BUPRENORPHINE 5 MCG/HR PATCH (NDC 50742037204) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.